
Sources:
— Sikiric et al. (2018), Current Pharmaceutical Design — BPC-157 comprehensive review
— Pickart et al. (2012), Oxidative Medicine and Cellular Longevity — GHK-Cu gene expression
— Bock-Marquette et al. (2004), Nature — Thymosin Beta-4 cardiac repair
— FDA Notice, March 2024 — BPC-157 compounding ban
English